Sun Pharma’s US subsidiary acquires Galderma’s companies in US, Japan & Canada
2022-03-09
Sun Pharma, India’s largest drug maker, said its step-down US subsidiary Taro Pharmaceuticals has acquired companies of Galderma in the US, Japan and Canada. Galderma specialises in skin related disorders. Taro has paid around $99.3 million after taking into account working capital adjustments. “Taro Pharmaceuticals USA, one of the wholly owned subsidiaries of our Taro…Continue Reading